Trade ALX Oncology Holdings Inc. - ALXO CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.11 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 6.1 |
| Open | 6.26 |
| 1-Year Change | 7.01% |
| Day's Range | 5.94 - 6.26 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 26, 2024 | 5.98 | -0.16 | -2.61% | 6.14 | 6.31 | 5.94 |
| Jul 25, 2024 | 6.03 | -0.10 | -1.63% | 6.13 | 6.37 | 5.95 |
| Jul 24, 2024 | 6.17 | -0.15 | -2.37% | 6.32 | 6.71 | 6.16 |
| Jul 23, 2024 | 6.60 | 0.06 | 0.92% | 6.54 | 6.76 | 6.48 |
| Jul 22, 2024 | 6.67 | 0.51 | 8.28% | 6.16 | 6.71 | 6.01 |
| Jul 19, 2024 | 6.09 | -0.48 | -7.31% | 6.57 | 6.57 | 6.05 |
| Jul 18, 2024 | 6.55 | -0.74 | -10.15% | 7.29 | 7.70 | 6.47 |
| Jul 17, 2024 | 7.62 | -0.32 | -4.03% | 7.94 | 8.04 | 7.59 |
| Jul 16, 2024 | 8.08 | 0.01 | 0.12% | 8.07 | 8.73 | 7.73 |
| Jul 15, 2024 | 7.96 | 0.94 | 13.39% | 7.02 | 7.98 | 6.83 |
| Jul 12, 2024 | 7.00 | -0.66 | -8.62% | 7.66 | 7.93 | 6.76 |
| Jul 11, 2024 | 7.64 | 0.91 | 13.52% | 6.73 | 7.94 | 6.72 |
| Jul 10, 2024 | 6.70 | 0.37 | 5.85% | 6.33 | 6.72 | 6.27 |
| Jul 9, 2024 | 6.32 | 0.73 | 13.06% | 5.59 | 6.32 | 5.34 |
| Jul 8, 2024 | 5.58 | 0.22 | 4.10% | 5.36 | 5.77 | 5.28 |
| Jul 5, 2024 | 5.40 | -0.06 | -1.10% | 5.46 | 5.69 | 5.25 |
| Jul 3, 2024 | 5.54 | -0.13 | -2.29% | 5.67 | 6.04 | 5.52 |
| Jul 2, 2024 | 5.68 | -0.08 | -1.39% | 5.76 | 5.97 | 5.65 |
| Jul 1, 2024 | 5.94 | 0.17 | 2.95% | 5.77 | 6.17 | 5.57 |
| Jun 28, 2024 | 5.96 | 0.34 | 6.05% | 5.62 | 6.15 | 5.50 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
ALX Oncology Holdings Inc. Company profile
About ALX Oncology Holdings Inc
ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company. The Company is focused on enabling patients to fight cancer by developing therapies that block the cluster of differentiation 47 (CD47) checkpoint pathway and bridge the innate and adaptive immune system. The Company is developing a checkpoint inhibitor designed to have an affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches. Its lead product candidate, ALX148, is a CD47 blocking therapeutic. ALX148 is a fusion protein that combines a CD47 binding domain with its inactivated fragment crystallizable (Fc) domain. The CD47 binding domain of ALX148 is an affinity enhanced extracellular domain of signal regulatory protein alpha (SIRPa), a protein that is the natural receptor to CD47 found on myeloid cells. Its programs are focused on targeting CD47 across various oncology indications.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, ALX Oncology Holdings Inc revenues decreased from $1.2M to $0K. Net loss applicable to common stockholders increased 64% to $83.5M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Reserach and developement increase of 76% to $46.5M (expense).
| Industry: | Bio Therapeutic Drugs |
323 Allerton Avenue
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com